Revelation Biosciences (REVB) News Today $1.59 -0.03 (-1.85%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period June 24, 2024 | businesswire.comRevelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker ActivityJune 13, 2024 | businesswire.comRevelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of GeminiMay 10, 2024 | investorplace.comREVB Stock Earnings: Revelation Biosciences Misses EPS for Q1 2024May 10, 2024 | businesswire.comRevelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024March 22, 2024 | businesswire.comRevelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023March 13, 2024 | finance.yahoo.comRevelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)March 4, 2024 | finance.yahoo.comRevelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of GeminiFebruary 13, 2024 | finance.yahoo.comRevelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)February 9, 2024 | msn.comRevelation Biosciences Secures $6.2M in Public OfferingFebruary 5, 2024 | finance.yahoo.comRevelation Biosciences Inc. Announces Closing of $6.2 Million Public OfferingFebruary 5, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. February 2, 2024 | marketwatch.comRevelation Biosciences Shares Slide Premarket on Public OfferingFebruary 1, 2024 | msn.comRevelation Biosciences to raise ~$6.2M through public offering of sharesFebruary 1, 2024 | investorplace.comWhy Is Revelation Biosciences (REVB) Stock Down 62% Today?January 31, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 31, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 30, 2024 | finance.yahoo.comRevelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)January 29, 2024 | seekingalpha.comFATE, NEXI and INBS among mid-day moversJanuary 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 11:01 AM with a stated reason of "LULD pause." Trading set to resume at 11:01 AM. January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 10:01 AM with a stated reason of "LULD pause." Trading set to resume at 11:01 AM. January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 10:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 10:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 10:01 AM with a stated reason of "LULD pause." Trading set to resume at 10:01 AM. January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 09:01 AM with a stated reason of "LULD pause."January 26, 2024 | finance.yahoo.comREVB Continues March to TrialsJanuary 25, 2024 | marketbeat.comTrading was temporarily halted for "REVB" at 07:01 PM with a stated reason of "News pending."January 23, 2024 | finance.yahoo.comRevelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024November 22, 2023 | morningstar.comRevelation Biosciences Inc Ordinary Shares REVBNovember 14, 2023 | finance.yahoo.comREVB Releases Earnings and Prepares for TrialsNovember 14, 2023 | msn.comRevelation Biosciences GAAP EPS of -$0.42November 13, 2023 | finance.yahoo.comRevelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023October 12, 2023 | finance.yahoo.comGemini Induces Pharmacologic Activity and Related Physiologic Changes in Multiple Preclinical StudiesOctober 4, 2023 | finance.yahoo.comRevelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities ConferenceOctober 2, 2023 | finance.yahoo.comRevelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of DirectorsAugust 14, 2023 | finance.yahoo.comREVB Reports Solid Balance Sheet and Remains on TrackAugust 11, 2023 | finance.yahoo.comRevelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2023June 29, 2023 | finance.yahoo.comREMINDER: Revelation Biosciences, Inc. Urges All Stockholders to Vote at the 2023 Annual Meeting of StockholdersJune 22, 2023 | finance.yahoo.comREVB: REVB Looks Attractive Ahead of TrialsJune 12, 2023 | finance.yahoo.comRevelation Biosciences Inc. Announces Adjournment of 2023 Annual Meeting of Stockholders to July 7, 2023 and Additional ProposalJune 6, 2023 | finance.yahoo.comREVB - Revelation Biosciences, Inc.May 22, 2023 | seekingalpha.comRevelation Biosciences GAAP EPS of $1.96May 22, 2023 | finance.yahoo.comRevelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2023 and Recent Corporate ProgressMarch 30, 2023 | finance.yahoo.comRevelation Biosciences Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Recent Corporate ProgressMarch 30, 2023 | seekingalpha.comREVB Revelation Biosciences, Inc.March 6, 2023 | finance.yahoo.comRevelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth ConferenceFebruary 9, 2023 | msn.comWhy Revelation Biosciences Is Trading 40% Lower ThursdayFebruary 9, 2023 | finance.yahoo.comRevelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering Get Revelation Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for REVB and its competitors with MarketBeat's FREE daily newsletter. Email Address NEW AI developed by trader who won 1,129% (in 2 days) (Ad)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans... Click here to see how >>> REVB Media Mentions By Week REVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REVB News Sentiment▼1.430.61▲Average Medical News Sentiment REVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REVB Articles This Week▼20▲REVB Articles Average Week Get Revelation Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for REVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NeuroSense Therapeutics News Today Aeterna Zentaris News Today Agile Therapeutics News Today Pieris Pharmaceuticals News Today Moleculin Biotech News Today ABVC BioPharma News Today Elevai Labs News Today Cyclerion Therapeutics News Today Molecular Templates News Today Purple Biotech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REVB) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revelation Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.